KEI statement on bipartisan trade agreement
14 May 2007
FMI: James Love james.love@keionline.org, +1.202.361.3040
On May 10, 2007, Speaker Nancy Pelosi and Ways and Means Chair Charles Rangel announced a “new bipartisan ” trade package. KEI has reviewed the details of the elements of section III of the agreement, concerning “patents, IPR and access to medicine.”
Continue Reading →
(When the shoe was on the other foot, Abbott asked for a compulsory license, while criticizing Thailand for issuing compulsory licenses) On the 12th of January 2007, Abbott Laboratories lost a bid in a U.S. District Court (the Western District… Continue Reading →
Schumer’s October 16, 2005 press release As Avian Flu Closes In On U.S., Schumer Calls For Immediate Action: Demands Suspension Of Tamiflu Patent So Vaccine Can Be Mass-Produced, Dramatically Increasing Supply Tamiflu, the Only Effective Treatment of Bird Flu in… Continue Reading →
Implementing TRIPS safeguards with particular attention to administrative models for compulsory licensing of patents WHO meeting in Harare, ZimbabweAugust 21, 2001(with additional references to November Doha declaration) James LoveConsumer Project on Technology I. Introduction. TRIPS obligations raise broad public health… Continue Reading →
Compulsory Licensing: Models For State Practice In Developing Countries, Access to Medicine and Compliance with the WTO TRIPS Accord Prepared for the United Nations Development Programme January 21, 2001 James Love Consumer Project on Technology http://www.cptech.org Introduction.1 This note addresses… Continue Reading →